| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.38B | 19.04B | 18.38B | 17.80B | 15.27B | 11.53B |
| Gross Profit | 2.02B | 1.73B | 1.49B | 1.73B | 495.00M | -2.02B |
| EBITDA | 1.28B | 1.31B | 621.00M | 993.00M | 3.77B | -542.00M |
| Net Income | 160.00M | 132.00M | -532.00M | 177.00M | 1.82B | -1.72B |
Balance Sheet | ||||||
| Total Assets | 29.62B | 30.03B | 30.20B | 29.15B | 30.16B | 29.45B |
| Cash, Cash Equivalents and Short-Term Investments | 5.47B | 5.86B | 6.55B | 7.74B | 9.25B | 7.27B |
| Total Debt | 13.31B | 14.70B | 14.89B | 13.52B | 14.16B | 16.41B |
| Total Liabilities | 20.44B | 20.77B | 20.95B | 19.68B | 20.86B | 22.12B |
| Stockholders Equity | 9.13B | 9.22B | 9.19B | 9.43B | 9.25B | 7.28B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -139.00M | -1.89B | -213.00M | 629.00M | -1.59B |
| Operating Cash Flow | 0.00 | 549.00M | 684.00M | 561.00M | 1.20B | -1.03B |
| Investing Cash Flow | 0.00 | 39.00M | -3.15B | -1.16B | 2.67B | -546.00M |
| Financing Cash Flow | 0.00 | -886.00M | 830.00M | -1.21B | -2.21B | 6.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥782.40B | 19.01 | 19.13% | 2.64% | 7.58% | 15.12% | |
66 Neutral | ¥129.22B | 8.08 | ― | 2.82% | 11.66% | -7.47% | |
63 Neutral | ¥60.58B | 10.40 | ― | 4.49% | 8.56% | -13.47% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
54 Neutral | ¥5.89B | 8.03 | ― | 0.72% | 5.64% | ― | |
53 Neutral | ¥242.78B | 16.36 | ― | 1.24% | 21.79% | 9.89% | |
48 Neutral | ¥4.59B | -10.59 | ― | 1.08% | -2.36% | -1738.42% |